Cinctive Capital Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-49,012
Closed -$2.28M 554
2022
Q3
$2.28M Buy
49,012
+19,012
+63% +$882K 0.1% 266
2022
Q2
$1.31M Sell
30,000
-85,874
-74% -$4.72M 0.06% 359
2022
Q1
$8.38M Buy
115,874
+68,417
+144% +$4.93M 0.31% 101
2021
Q4
$3.85M Buy
47,457
+14,671
+45% +$1.47M 0.17% 200
2021
Q3
$3.82M Buy
+32,786
New +$4.29M 0.19% 192
2020
Q3
Sell
-10,750
Closed -$1.28M 382
2020
Q2
$1.28M Buy
+10,750
New +$1.28M 0.15% 219
2020
Q1
Sell
-15,225
Closed -$1.79M 294
2019
Q4
$1.79M Buy
+15,225
New +$1.51M 0.19% 166

Other funds holding NVRO

Cinctive Capital Management's NVRO Position: Q4 2022 in Review

Cinctive Capital Management sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 49,012 shares — an estimated $2.28M sold.

Cinctive Capital Management first reported a position in NVRO in Q4 2019 and held it in 7 quarters. The position peaked at $8.38M in Q1 2022. 169 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

  • Cinctive Capital Management reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 49,012 NEVRO CORP. shares in Q4 2022, an estimated $2.28M.
  • Cinctive Capital Management first reported a position in NEVRO CORP. in Q4 2019 and held it in 7 quarters.
  • Cinctive Capital Management's NEVRO CORP. position peaked at $8.38M in Q1 2022.
  • 169 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on Cinctive Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.